Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression

Swindells, Susan; Andrade‐Villanueva, Jaime; Richmond, Gary; Rizzardini, Giuliano; Baumgarten, Axel; Masiá, Mar; Latiff, Gulam; Pokrovsky, Vadim; Bredeek, Fritz; Smith, Graham; Cahn, Pedro; Ys, Kim; L. Ford, Susan; L. Talarico, Christine; Patel, Parul; Chounta, Vasiliki; Crauwels, Herta; Parys, Wim; Vanveggel, Simon; Mrus, Joseph; Huang, Jenny; Harrington, Conn; J Hudson, Krischan; A. Margolis, David; Y. Smith, Kimberly; Williams, Peter; Spreen, William

doi:10.1056/nejmoa1904398

Public

Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression

Published in New England Journal of Medicine • Mar 4, 2020

Authors:

Susan Swindells

Jaime Andrade‐Villanueva

Gary Richmond

Abstract

BACKGROUND: Simplified regimens for the treatment of human immunodeficiency virus type 1 (HIV-1) infection may increase patient satisfaction and facilitate adherence. METHODS: In this phase 3, open-label, multicenter, noninferiority trial involving patients who had had plasma HIV-1 RNA levels of les...

Subject

Rilpivirine

Medicine

Confidence interval

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!